Austin, TX (PRWEB) December 31, 2013
Hissey Kientz, LLP reports that the DePuy Orthopaedics division of Johnson & Johnson could pay $4 billion to settle thousands of DePuy ASR hip replacement lawsuits, according to an article published on November 19, 2013 in the New York Times. Johnson & Johnson has already agreed to a settlement amount of at least $2.47 billion.*
This DePuy Orthopaedics settlement will resolve approximately 8,000 DePuy lawsuits filed by patients who had to have their hip replacement surgically removed. Johnson & Johnson is currently facing nearly 12,000 DePuy lawsuits filed in federal courts and state courts in California, Illinois and New Jersey.**
DePuy lawsuits were filed after Johnson & Johnson issued a recall of 93,000 DePuy ASR hip implants worldwide in August 2010, reporting that 12 percent failed within five years. Additional problems relating to DePuy hip replacement failure can include hip implant loosening, metal poisoning from elevated cobalt and chromium levels, fractures at the site of the implant and dislocation of the hip device. ***
Plaintiffs must have had the DePuy ASR hip implanted in the U.S. and had it removed by Aug. 31, 2013 to be eligible for this settlement. Patients must have had the DePuy implant for at least 180 days before having it removed. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197)
Patients who have experienced complications from a DePuy hip replacement may wish to speak with a lawyer to find out if they are eligible to file a lawsuit. For a free DePuy lawsuit consultation, contact the attorneys at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by email at info(at)hkllp(dot)com.
About Hissey Kientz, LLP
Hissey Kientz, LLP (http://www.hkllp.com) represents patients who received recalled DePuy hip replacements, as well as as well as victims of mesothelioma and other asbestos-related diseases, birth defects linked to the antidepressant drugs Zoloft, Lexapro, Celexa and Effexor, GranuFlo and NaturaLyte acid concentrates, Stryker and BioMet hip replacements, transvaginal mesh implants, Mirena IUDs and other defective drugs and medical devices.